VCM
MIRM icon

Versant Capital Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Versant Capital Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.2K Buy
70
+12
+21% +$1.21K ﹤0.01% 2290
2026
Q1 		$5.36K Hold
58
– – ﹤0.01% 2361
2025
Q4 		$4.58K Hold
58
– – ﹤0.01% 2285
2025
Q3 		$4.25K Buy
58
+54
+1,350% +$3.43K ﹤0.01% 2270
2025
Q2 		$204 Buy
+4
New +$178 ﹤0.01% 2595

Other funds holding MIRM

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
SAM
Secure Asset Management Troy, Michigan $714M AUM 27.91% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
EA
Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
JWS
Juncture Wealth Strategies Scottsdale, Arizona $384M AUM 27.62% 1-Year Est. Return
CIM
Contravisory Investment Management Norwell, Massachusetts $566M AUM 42.93% 1-Year Est. Return

Versant Capital Management's MIRM Position: Q2 2026 in Review

Versant Capital Management increased its Mirum Pharmaceuticals (MIRM) stake by 21% in Q2 2026, buying an estimated $1.21K and bringing the position to 70 shares worth $8.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2290.

Versant Capital Management first reported a position in MIRM in Q2 2025 and has held it in 5 quarters since. 22 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Versant Capital Management held 70 shares of Mirum Pharmaceuticals worth $8.2K as of Q2 2026.
  • Versant Capital Management bought 12 Mirum Pharmaceuticals shares in Q2 2026, an estimated $1.21K.
  • Mirum Pharmaceuticals made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #2290 holding.
  • Versant Capital Management first reported a position in Mirum Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 22 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.